Granisetron Hydrochloride (Page 4 of 4)

HOW SUPPLIED

White to off-white film coated triangular shaped biconvex tablet debossed with “G1” on one side and plain on the other side.


1 mg Bottle of 20 Tablets: NDC 42043-390-20


1 mg Unit of Use 2s: NDC 42043-390-02

1 mg 20 (2 x 10) Unit Dose Tablets: NDC 42043-390-21 (intended for institutional use only)

Storage

Store between 20° and 25°C (68° and 77°F). [see USP Controlled Room Temperature]. Keep container closed tightly. Protect from light.

PATIENT COUNSELING INFORMATION

Advise patients of the possibility of serotonin syndrome with concomitant use of granisetron and another serotonergic agent such as medications to treat depression and migraines. Advise patients to seek immediate medical attention if the following symptoms occur: changes in mental status, autonomic instability, neuromuscular symptomswith or without gastrointestinal symptoms.

Manufactured for : OrchidPharma, Inc.

Princeton, NJ 08540, USA

Manufactured by : Orchid Healthcare

(a division of Orchid Pharma Ltd.)

Irungattukottai — 602 117, India

Revised:11/2018

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

OrchidPharma

NDC 42043-390-20

Granisetron Hydrochloride Tablets, USP

1 mg*

20 Tablets

Rx only

Container Label
(click image for full-size original)

OrchidPharma

20 (2 x 10)

Unit Dose Tablets

NDC 42043-390-21

Granisetron Hydrochloride Tablets, USP

1 mg*

Rx only

* Each tablet contains 1.12 mg granisetron hydrochloride USP equivalent to granisetron, 1 mg.

Intended For Institutional Use Only.

Blister Carton 2s
(click image for full-size original)
GRANISETRON HYDROCHLORIDE granisetron hydrochloride tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42043-390
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GRANISETRON HYDROCHLORIDE (GRANISETRON) GRANISETRON 1 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
LACTOSE MONOHYDRATE
HYPROMELLOSE 2910 (3 MPA.S)
MAGNESIUM STEARATE
Product Characteristics
Color white (white to off white) Score no score
Shape TRIANGLE (Triangular Biconvex) Size 7mm
Flavor Imprint Code G1
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:42043-390-02 2 BLISTER PACK in 1 CARTON contains a BLISTER PACK (42043-390-00)
1 NDC:42043-390-00 1 TABLET, FILM COATED in 1 BLISTER PACK This package is contained within the CARTON (42043-390-02)
2 NDC:42043-390-21 2 BLISTER PACK in 1 CARTON contains a BLISTER PACK (42043-390-40)
2 NDC:42043-390-40 10 TABLET, FILM COATED in 1 BLISTER PACK This package is contained within the CARTON (42043-390-21)
3 NDC:42043-390-20 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078678 04/12/2016
Labeler — OrchidPharma Inc (809429207)
Registrant — Orchid Pharma Ltd (650133507)
Establishment
Name Address ID/FEI Operations
Orchid Healthcare (a division of Orchid Pharma Ltd) 650288850 analysis (42043-390), manufacture (42043-390), pack (42043-390), label (42043-390)

Revised: 01/2022 OrchidPharma Inc

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.